Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the quick ratio (acid-test) high or low?
The quick ratio (acid-test) of 2.77 is 16% below its 5-year average of 3.28, near the low end of its 5-year range (0.00–20.00).
As of the fiscal period ended Tuesday, June 30, 2026. 6.82% above its 12-month average of 2.59.
Reported quarterly quick ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 2.77.
QUICK RATIO (ACID-TEST)
2.77
QUICK RATIO (ACID-TEST) AVG TTM
2.59
QUICK RATIO (ACID-TEST) AVG 3Y
2.32
QUICK RATIO (ACID-TEST) AVG 5Y
3.28
QUICK RATIO (ACID-TEST) AVG 10Y
N/A
QUICK RATIO (ACID-TEST) AVG 15Y
N/A
QUICK RATIO (ACID-TEST) AVG 20Y
N/A
CURRENT VS TTM AVG
+6.82%
CURRENT VS 3Y AVG
+19.57%
CURRENT VS 5Y AVG
-15.65%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
3.19
median of 736 covered companies
CURRENT VS SECTOR MEDIAN
-13.18%
vs the sector median at left
Elicio Therapeutics, Inc.
Market Cap
$36.80M
Quick Ratio (Acid-Test)
2.77
TTM Avg
2.59
3Y Avg
2.32
5Y Avg
3.28
Market Cap
$36.70M
Quick Ratio (Acid-Test)
2.76
TTM Avg
5.79
3Y Avg
4.84
5Y Avg
5.49
Market Cap
$36.63M
Quick Ratio (Acid-Test)
2.06
TTM Avg
1.18
3Y Avg
0.60
5Y Avg
0.79
Market Cap
$38.35M
Quick Ratio (Acid-Test)
48.81
TTM Avg
25.84
3Y Avg
15.89
5Y Avg
15.79
Market Cap
$35.23M
Quick Ratio (Acid-Test)
7.07
TTM Avg
2.75
3Y Avg
16.37
5Y Avg
28.22
Market Cap
$38.88M
Quick Ratio (Acid-Test)
0.98
TTM Avg
0.82
3Y Avg
0.91
5Y Avg
1.06
Market Cap
$34.58M
Quick Ratio (Acid-Test)
11.47
TTM Avg
9.93
3Y Avg
10.68
5Y Avg
16.03
| NAME | MARKET CAP | QUICK RATIO (ACID-TEST) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Elicio Therapeutics, Inc. (ELTX) | $36.80M | 2.77 | 2.59 | 2.32 | 3.28 |
| Edesa Biotech, Inc. (EDSA)vs › | $36.70M | 2.76 | 5.79 | 4.84 | 5.49 |
| QT Imaging Holdings, Inc. (QTI)vs › | $36.63M | 2.06 | 1.18 | 0.60 | 0.79 |
| DocGo Inc. (DCGO)vs › | $35.92M | 1.66 | 2.38 | 2.35 | 2.72 |
| Incannex Healthcare Limited (IXHL)vs › | $38.35M | 48.81 | 25.84 | 15.89 | 15.79 |
| BriaCell Therapeutics Corp. (BCTX)vs › | $35.23M | 7.07 | 2.75 | 16.37 | 28.22 |
| Elutia Inc (ELUT)vs › | $35.15M | 1.64 | 1.38 | 1.12 | 1.30 |
| Harvard Bioscience, Inc. (HBIO)vs › | $38.88M | 0.98 | 0.82 | 0.91 | 1.06 |
| Grace Therapeutics, Inc. (GRCE)vs › | $34.58M | 11.47 | 9.93 | 10.68 | 16.03 |
| Accuray Incorporated (ARAY)vs › | $34.37M | 0.74 | 0.82 | 0.89 | 0.96 |
Quick Ratio
2.77
Excludes inventory
Current Ratio
2.77
Includes inventory
Quick Ratio = (Current Assets − Inventory) / Current Liabilities
The quick ratio is a stricter liquidity measure that excludes inventory, showing the ability to meet short-term obligations with the most liquid assets.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | QUICK RATIO (ACID-TEST) |
|---|---|
| 2026-06-30 | 2.77 |
| 2026-03-31 | 2.24 |
| 2025-12-31 | 2.38 |
| 2025-09-30 | 3.29 |
| 2025-06-30 | 2.28 |
| 2025-03-31 | 1.83 |
| 2024-12-31 | 1.80 |
| 2024-09-30 | 3.40 |
| 2024-06-30 | 0.88 |
| 2024-03-31 | 2.37 |
| 2023-12-31 | 1.68 |
| 2023-09-30 | 1.74 |
| 2023-06-30 | 3.45 |
| 2023-03-31 | 20.00 |
| 2022-12-31 | 1.56 |
| 2022-09-30 | 6.93 |
| 2022-06-30 | 0.00 |
| 2022-03-31 | 7.34 |
| 2021-12-31 | 8.08 |
| 2021-09-30 | 5.82 |
| 2021-06-30 | 5.83 |
| 2021-03-31 | 4.29 |
| 2020-12-31 | 0.38 |
| 2020-09-30 | 0.19 |
| 2020-06-30 | 0.00 |
| 2020-03-31 | 0.00 |
| 2019-12-31 | 0.23 |
